Vadivelu Comedy News

Kushandiswa kwe tricoumaroyl spermidine CAS 131086-78-7

2023-12-05

Tricoumaroyl spermidine CAS 131086-78-7, komboni yave kutariswa nekugona kushandiswa kwayo munzvimbo dzakasiyana siyana. Ichi chinyorwa chinyorwa chinobva kune spermidine, yakasikwa polyamine yakakosha pakukura kwesero uye kupatsanura. Kuwedzerwa kwe tricoumaroyl kune spermidine kunowedzera iyo biological uye pharmacological zvimiro, zvichiita kuti ive komisheni inovimbisa yekuwedzera kutsvagisa nekusimudzira.


Zvidzidzo zvakasiyana-siyana zvakaratidza kuti tricoumaroyl spermidine CAS 131086-78-7 ine anti-inflammatory, antioxidant, uye neuroprotective madhara. Zvinotendwa kuti tricoumaroyl spermidine inogona kubatsira kuderedza kuzvimba uye oxidative kusagadzikana mumuviri, nekudaro kuvandudza hutano hwese uye kugara zvakanaka. Pamusoro pezvo, zvakataurwa kuti tricoumaroyl spermidine inogona kuve ine mukana mukurapa neurodegenerative zvirwere, senge Alzheimer's uye Parkinson's.


Tricoumaroyl spermidine iri kuwanawo kutarisisa mumunda wezvizoro. Zvidzidzo zvekutanga zvakaratidza kuti inogona kunge iine maapplication mu-anti-aging skincare zvigadzirwa nekuda kwekugona kwayo kusimudzira kugadzirwa kwe collagen uye kuderedza kutaridzika kwemitsara yakanaka uye wrinkles. Uyezve, tricoumaroyl spermidine yakawanikwa inoratidzira antimicrobial properties, zvichiita kuti ive chinhu chinogona kuitika muzvigadzirwa zvekuchengetedza zvemunhu zvinovavarira kurwisa mabhakitiriya anokuvadza.


Pakazara,tricoumaroyl spermidine CAS 131086-78-7, ikomboni inovimbisa ine huwandu hwezvinogona kushandiswa. Yayo yakasarudzika biological uye pharmacological zvimiro zvinoita kuti ive inonakidza nzvimbo yekutsvagisa yesainzi nenyanzvi dzehutano pasirese. Sezvo dzimwe ongororo dzichiitwa, tricoumaroyl spermidine inogona kukurumidza kuve chinhu chakakosha mune dzakasiyana siyana, kusanganisira mushonga, zvizorwa, uye kutarisira wega.




X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept